All our products are manufactured to the highest quality standards in strict accordance with the regulations of the national and European medicines agencies. The harvesting procedure for the adipose tissue is performed in our certified collection centers by specially trained physicians. Our team of highly qualified scientists in research and development works to continuously expand our product line.

Powerful products with huge potential.

Up to now, Oxacell AG has developed 3 ready-to-use stem cell products:

Oxacells CAL (cell-assisted lipotransfer) is a versatile product. For the production, stem cells are obtained from endogenous adipose tissue and then mixed with a small portion of the fat (lipofilling) for injection (enriched lipotransfer). The result is a stem cell-based product that improves the skin and subcutaneous tissue structure.
This enrichment process results in drastically improved characteristic of CAL when compared to the conventional fat cell transplantation: The subcutaneous fatty tissue is rebuild sustainably, scarred tissue and wrinkles are smoothened. CAL is a natural alternative to silicone implants for breast augmentation. Likewise, breast reconstruction after amputation or partial amputation can be achieved naturally without scars. Furthermore, CAL is particular suitable for treating damage of skin and subcutaneous adipose tissue after burns or radiation.

Oxacells HP (high purity) is a cell-based ATMP (Advanced Therapy Medicinal Product) intended for the autologous treatment of osteoarthritis in all joints. This medicinal product contains highly purified adult stem cells derived from adipose tissue.

The following joints are included in the manufacturing license:

  • Knekle
  • Ankle joint
  • Toe joints
  • Shoulder-joint
  • Coxofemoral joint
  • Elbow joint
  • Intervertebral joints
  • Temporomandibular joint

Our latest development is Oxacells CULT, cultivated, highly potent stem cells derived from adipose tissue. Due to its excellent immune-modulatory and anti-inflammatory properties, this product is ideally suited for allogenic applications, including liver diseases (acute liver failure, cirrhosis) as well as autoimmune disease such as multiple sclerosis, lupus or type 1 diabetes.

In comparison to similar products, CULT is a ready-to-use product: additional manipulation (thawing/ elimination of cryoprotectants) at the site of treatment becomes obsolete. Our carefully balanced formulation (patent pending) greatly extends the shelf-life of CULT, guaranteeing worldwide distribution at 4°C.

Copyright © 2018 Oxacell AG | Helene-Lange-Straße 12, 14469 Potsdam | Tel. +49 (0)331 - 24 34 63 96 | e-mail: